Detalhe da pesquisa
1.
Vertebrate-class-specific binding modes of the alphavirus receptor MXRA8.
Cell
; 186(22): 4818-4833.e25, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804831
2.
Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice.
Cell
; 185(9): 1572-1587.e11, 2022 04 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35452622
3.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
; 54(10): 2399-2416.e6, 2021 10 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34481543
4.
Computationally restoring the potency of a clinical antibody against Omicron.
Nature
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38720086
5.
Neutralization, effector function and immune imprinting of Omicron variants.
Nature
; 621(7979): 592-601, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648855
6.
SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
Nature
; 603(7902): 687-692, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35062015
7.
prM-reactive antibodies reveal a role for partially mature virions in dengue virus pathogenesis.
Proc Natl Acad Sci U S A
; 120(3): e2218899120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36638211
8.
Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2.
Nat Microbiol
; 8(4): 569-580, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37012355
9.
A broadly reactive antibody targeting the N-terminal domain of SARS-CoV-2 spike confers Fc-mediated protection.
Cell Rep Med
; 4(12): 101305, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38039973
10.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice.
Nat Med
; 29(1): 247-257, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265510
11.
Domain-based mRNA vaccines encoding spike protein N-terminal and receptor binding domains confer protection against SARS-CoV-2.
Sci Transl Med
; 15(713): eadf4100, 2023 09 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703353
12.
Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants.
bioRxiv
; 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36324800
13.
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants.
bioRxiv
; 2023 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711984
14.
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2.
bioRxiv
; 2022 Nov 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36482975
15.
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2.
Med
; 3(5): 309-324.e6, 2022 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35584653
16.
Development of SARS-CoV-2 mRNA vaccines encoding spike N-terminal and receptor binding domains.
bioRxiv
; 2022 Oct 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36238717
17.
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant.
bioRxiv
; 2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263060
18.
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains.
Sci Transl Med
; 14(630): eabm3302, 2022 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34846168
19.
Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B.1.1.529 infection in mice.
bioRxiv
; 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35169795
20.
Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains.
Nat Commun
; 13(1): 3824, 2022 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780162